PHILADELPHIA , Aug. 18, 2025 /PRNewswire/ -- Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, after a class action lawsuit was filed against Novo. Investor Deadline: Investors who purchased or acquired Novo securities between May 7, 2025 through July 28, 2025 (the "Class Period"), may, no later than September 30, 2025 , seek to be appointed as a lead plaintiff representative of the class.

The Trump administration is reportedly in discussions to acquire a roughly 10% stake in Intel Corp (NASDAQ:INTC, ETR:INL), a move that could make the US government the chipmaker's largest shareholder, Bloomberg News reported on Monday. A 10% holding in the American semiconductor giant would be worth around $10 billion.

EXK posts a Q2 loss despite a 46% rise in revenues, as higher costs and weaker gold output weigh on results.

Baidu is a value buy, overlooked amid China's AI and autonomous driving growth, offering strong GARP potential despite weak core advertising. Advertising and iQIYI revenues are under pressure, but I believe the downturn is cyclical and the ad business still has a solid floor. AI Cloud and non-marketing revenues are growing rapidly, now comprising 29% of total revenue and driving future topline growth.

NEW YORK--(BUSINESS WIRE)---- $UNCY #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) and reminds investors of the October 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Geor.

Novo Nordisk A/S's FDA approval for Wegovy in MASH and aggressive Ozempic pricing boost its position, despite recent stock declines and competitive pressure from Eli Lilly and Company. Both NVO and LLY face regulatory headwinds from U.S. drug pricing demands, but I believe much of the bad news is already priced in for both. Novo's strategic pricing, strong clinical data, and attractive valuation make it my preferred long-term pick, though both stocks offer upside from current levels.

TBT offers -2x daily performance of 20+ Year Treasury Bonds, but is highly risky and unsuitable for long-term holding due to value decay. Leveraged inverse ETFs like TBT can experience significant compounding effects and performance drift if held beyond a single day, amplifying potential losses. Macroeconomic factors and likely Fed rate cuts in September 2025 could drive long-term Treasury yields lower, making TBT vulnerable to further declines.

Human resources and finance platform Workday suffered a data breach in which fraudsters accessed some information from its third-party customer relationship management (CRM) platform.

BIDU eyes AI gains, but macro weakness, falling ad spend and high costs may drag Q2 earnings sharply lower.

PEP beats Q2 expectations with pricing power. However, soft volumes and long-term growth questions loom.

AST SpaceMobile faces earnings miss and macro headwinds, yet its manufacturing footprint expansion and telecom partnerships keep growth hopes alive.

Okeanis Eco Tankers Corp. (ECO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

JELD-WEN (JELD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Lincoln Electric Holdings (LECO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Palantir Technologies Inc. (PLTR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sonos (SONO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Donald Trump meets with Ukrainian President Volodymyr Zelenskyy and European leaders.

Tesla posted a new video on Chinese social media showing off the Model Y L, a longer wheelbase variant of the popular vehicle. Translated from Chinese, the post said that the Model Y L is "coming soon.

ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced it will participate in upcoming conferences. Jeff Niew, President and CEO of Knowles will participate in The Jefferies Industrial Conference in New York City on September 3, 2025. Contact your Jefferies representative to schedul.